Silver Book Fact

Healthcare costs of atrial fibrillation

Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations at 9%, further investigations at 8%, loss of work at 6%, and paramedical procedures at 2%.

Le Heuzey J, Paziaud O, Piot O, Ait S, et al. Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study. Am Heart J. 2004; 147(1): 121-6. https://pubmed.ncbi.nlm.nih.gov/14691429/

Reference

Title
Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study
Publication
Am Heart J
Publication Date
2004
Authors
Le Heuzey J, Paziaud O, Piot O, Ait S, et al.
Volume & Issue
Volume 147, Issue 1
Pages
121-6
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib prevalence, 2006
    As much as 1% of the U.S. population is estimated to have atrial fibrillation  
  • Annual cost of treating privately insured patients for AFib
    The annual cost of treating privately insured patients for atrial fibrillation (AF) is $12,350 per patient— approximately 5 times greater than treating patients without AF.  
  • Atrial fibrillation prevalence projection, 2050
    Atrial fibrillation prevalence is projected to rise to between 5.6 and 12.1 million in 2050.  
  • AFib patient hospital visits
    Individuals with atrial fibrillation (AF) are 4 times more likely to visit the hospital 3 or more times in the year following an AF diagnosis—compared to those without the disease.  
  • Atrial fibrillation prevalence, 2012
    Atrial fibrillation is estimated to impact between 2.7 and 6.1 million Americans.